Bacticon was founded in 2013 when Dr Martin Alm in an extraordinary collaboration with a university made a novel particle engineering technology which is transforming the pharmaceutical industry.

The Zwitterionic Particle (ZPART) process was discovered in 2019. Since then Bacticon has expanded rapidly transforming into a company with global ambition. Our leading ZPART services are inteded to help the global pharmaceutical industry triple its annual new medicines output. This places Bacticon as a leading Danish innovator with an international outlook.